NasdaqGS - Nasdaq Real Time Price USD

Masimo Corporation (MASI)

Compare
172.29
+2.35
+(1.38%)
At close: January 17 at 4:00:01 PM EST
172.29
0.00
(0.00%)
After hours: January 17 at 4:20:00 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,042,600.00
2,048,100.00
2,035,800.00
1,239,200.00
1,143,700.00
Cost of Revenue
1,020,200.00
1,044,600.00
977,000.00
430,800.00
400,700.00
Gross Profit
1,022,400.00
1,003,500.00
1,058,800.00
808,400.00
743,000.00
Operating Expense
865,200.00
839,200.00
848,800.00
532,600.00
487,700.00
Operating Income
157,200.00
164,300.00
210,000.00
275,800.00
255,300.00
Net Non Operating Interest Income Expense
-42,900.00
-47,300.00
-23,900.00
600.00
5,200.00
Other Income Expense
-34,800.00
-28,900.00
7,300.00
-2,000.00
3,200.00
Pretax Income
79,500.00
88,100.00
193,400.00
274,400.00
263,700.00
Tax Provision
900.00
6,600.00
49,900.00
44,800.00
23,400.00
Net Income Common Stockholders
78,600.00
81,500.00
143,500.00
229,600.00
240,300.00
Diluted NI Available to Com Stockholders
78,600.00
81,500.00
143,500.00
229,600.00
240,300.00
Basic EPS
1.48
1.54
2.68
4.16
4.39
Diluted EPS
1.45
1.51
2.60
3.98
4.14
Basic Average Shares
53,100.00
52,800.00
53,600.00
55,166.00
54,700.00
Diluted Average Shares
54,400.00
54,100.00
55,200.00
57,682.00
58,037.00
Total Operating Income as Reported
136,400.00
136,500.00
210,000.00
275,800.00
255,800.00
Total Expenses
1,885,400.00
1,883,800.00
1,825,800.00
963,400.00
888,400.00
Net Income from Continuing & Discontinued Operation
78,600.00
81,500.00
143,500.00
229,600.00
240,300.00
Normalized Income
113,006.04
108,261.40
138,083.40
231,274.00
237,384.80
Interest Income
4,500.00
3,000.00
1,800.00
900.00
5,500.00
Interest Expense
47,400.00
50,300.00
25,700.00
300.00
300.00
Net Interest Income
-42,900.00
-47,300.00
-23,900.00
600.00
5,200.00
EBIT
126,900.00
138,400.00
219,100.00
274,700.00
264,000.00
EBITDA
221,600.00
236,700.00
355,200.00
310,300.00
293,300.00
Reconciled Cost of Revenue
1,020,200.00
1,044,600.00
977,000.00
430,800.00
400,700.00
Reconciled Depreciation
94,700.00
98,300.00
136,100.00
35,600.00
29,300.00
Net Income from Continuing Operation Net Minority Interest
78,600.00
81,500.00
143,500.00
229,600.00
240,300.00
Total Unusual Items Excluding Goodwill
-34,800.00
-28,900.00
7,300.00
-2,000.00
3,200.00
Total Unusual Items
-34,800.00
-28,900.00
7,300.00
-2,000.00
3,200.00
Normalized EBITDA
256,400.00
265,600.00
347,900.00
312,300.00
290,100.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-393.96
-2,138.60
1,883.40
-326.00
284.80
12/31/2020 - 8/8/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ARAY Accuray Incorporated
2.2400
-2.61%
 
GMED Globus Medical, Inc.
90.80
+0.36%
 
PEN Penumbra, Inc.
263.69
+0.53%
 
INSP Inspire Medical Systems, Inc.
177.68
+2.21%
 
IRTC iRhythm Technologies, Inc.
108.33
+1.25%
 
PODD Insulet Corporation
275.81
+1.08%
 
STE STERIS plc
209.62
-0.25%
 
NARI Inari Medical, Inc.
79.55
+0.19%
 
CNMD CONMED Corporation
67.69
+1.24%
 
BIO Bio-Rad Laboratories, Inc.
342.41
-0.60%